Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.

Resistance to chemotherapy and endocrine therapy is a major cause of breast cancer treatment failure. We have synthesized six novel analogues using C8-ceramide as the lead analogue and studied their effect on hormone therapy resistant (MDA-MB-231) and chemoresistant (MCF-7TN-R) breast cancer cells. Pharmacologic intervention using these ceramide analogues inhibited clonogenic survival and induced apoptosis, with one analogue being more effective than C8-ceramide. Our results show ceramide-based therapy has therapeutic potential in treating drug resistant breast cancer.

[1]  H. Ackermann,et al.  Ceramide synthases and ceramide levels are increased in breast cancer tissue. , 2009, Carcinogenesis.

[2]  A. Giuliano,et al.  A role for ceramide in driving cancer cell resistance to doxorubicin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. Giuliano,et al.  Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. , 2007, Biochimica et biophysica acta.

[4]  C. Elmets,et al.  Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors. , 2007, Cancer research.

[5]  H. Wanebo,et al.  Paclitaxel and Ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells , 2006, Oncology reports.

[6]  Yan Tang,et al.  Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. , 2004, International journal of oncology.

[7]  Yan Tang,et al.  Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer , 2004, Journal of Pharmacology and Experimental Therapeutics.

[8]  M. Burow,et al.  Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System , 2003, Experimental biology and medicine.

[9]  W. Linehan,et al.  MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity. , 2003, Molecular cancer therapeutics.

[10]  J. A. Shabbits,et al.  P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. , 2002, Molecular cancer therapeutics.

[11]  A. Giuliano,et al.  Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. , 1999, International journal of oncology.

[12]  A E Giuliano,et al.  Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[13]  R. Stancou,et al.  Analysis of Human Breast Adenocarcinoma MCF7 Resistance to Tumor Necrosis Factor-induced Cell Death , 1998, The Journal of Biological Chemistry.